Home › Obesity › Texas › Round Rock
Obesity clinical trials in Round Rock, TX
4 studies for Obesity are looking for participants at sites in and around Round Rock (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
RecruitingPhase 2
- Texas Diabetes & Endocrinology, P.A., Round Rock
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RecruitingPhase 4
- Austin Institute for Clinical Research, Pflugerville · 6 mi away
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Baylor Scott & White Health, Round Rock
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
RecruitingPhase 2
- Be Well Clinical Studies - Round Rock, Round Rock
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX44 studies
- Chicago, IL42 studies
- New York City, NY40 studies
- San Antonio, TX39 studies
- Washington, DC33 studies
- Dallas, TX31 studies
- Orlando, FL29 studies
- Boston, MA28 studies
- Miami, FL27 studies
- Las Vegas, NV27 studies
- Atlanta, GA25 studies
- Jacksonville, FL25 studies
Other studies in Round Rock
- Parkinson's Disease10 studies
- Ulcerative Colitis8 studies
- Steatotic Liver Disease7 studies
- Crohn's Disease7 studies
- Inflammatory Bowel Disease5 studies
- Non-Small Cell Lung Cancer4 studies
- Alzheimer's Disease4 studies
- Type 2 Diabetes4 studies
- Colorectal Cancer3 studies
- Mild Cognitive Impairment3 studies
- Liver Diseases3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.